nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—PTGS2—skin cancer	0.202	1	CbGaD
Ibuprofen—BCL2—Docetaxel—skin cancer	0.156	0.295	CbGbCtD
Ibuprofen—ABCC1—Vemurafenib—skin cancer	0.0644	0.122	CbGbCtD
Ibuprofen—ABCC1—Dactinomycin—skin cancer	0.0428	0.081	CbGbCtD
Ibuprofen—ALB—Vismodegib—skin cancer	0.0376	0.0711	CbGbCtD
Ibuprofen—ABCC4—Fluorouracil—skin cancer	0.036	0.0681	CbGbCtD
Ibuprofen—ALB—Vemurafenib—skin cancer	0.0297	0.0562	CbGbCtD
Ibuprofen—CYP2C8—Vismodegib—skin cancer	0.029	0.0549	CbGbCtD
Ibuprofen—CYP2C19—Vismodegib—skin cancer	0.0244	0.0461	CbGbCtD
Ibuprofen—ABCC1—Docetaxel—skin cancer	0.0221	0.0418	CbGbCtD
Ibuprofen—CYP2C9—Vismodegib—skin cancer	0.0202	0.0383	CbGbCtD
Ibuprofen—ABCB1—Vismodegib—skin cancer	0.0197	0.0372	CbGbCtD
Ibuprofen—CFTR—sweat gland—skin cancer	0.015	0.173	CbGeAlD
Ibuprofen—ALB—Fluorouracil—skin cancer	0.0133	0.0253	CbGbCtD
Ibuprofen—ABCB1—Dactinomycin—skin cancer	0.0103	0.0195	CbGbCtD
Ibuprofen—CYP2C8—Fluorouracil—skin cancer	0.0103	0.0195	CbGbCtD
Ibuprofen—CFTR—nose—skin cancer	0.0086	0.0994	CbGeAlD
Ibuprofen—CYP2C9—Fluorouracil—skin cancer	0.00719	0.0136	CbGbCtD
Ibuprofen—ABCB1—Docetaxel—skin cancer	0.00533	0.0101	CbGbCtD
Ibuprofen—PPARG—dermis—skin cancer	0.00326	0.0377	CbGeAlD
Ibuprofen—THBD—endothelium—skin cancer	0.00294	0.034	CbGeAlD
Ibuprofen—THBD—blood vessel—skin cancer	0.00271	0.0314	CbGeAlD
Ibuprofen—PPARG—leg—skin cancer	0.00215	0.0249	CbGeAlD
Ibuprofen—PPARG—forelimb—skin cancer	0.00214	0.0247	CbGeAlD
Ibuprofen—FABP2—epithelium—skin cancer	0.00207	0.0239	CbGeAlD
Ibuprofen—THBD—nipple—skin cancer	0.00196	0.0227	CbGeAlD
Ibuprofen—PPARG—hindlimb—skin cancer	0.00192	0.0222	CbGeAlD
Ibuprofen—PPARG—appendage—skin cancer	0.00165	0.0191	CbGeAlD
Ibuprofen—PLAT—nipple—skin cancer	0.00138	0.016	CbGeAlD
Ibuprofen—BCL2—neck—skin cancer	0.00137	0.0158	CbGeAlD
Ibuprofen—THBD—epithelium—skin cancer	0.00132	0.0153	CbGeAlD
Ibuprofen—CXCL8—nipple—skin cancer	0.00128	0.0148	CbGeAlD
Ibuprofen—THBD—skin of body—skin cancer	0.00126	0.0145	CbGeAlD
Ibuprofen—THBD—mammalian vulva—skin cancer	0.00115	0.0132	CbGeAlD
Ibuprofen—PTGS2—leg—skin cancer	0.0011	0.0127	CbGeAlD
Ibuprofen—THBD—lymphoid tissue—skin cancer	0.00102	0.0118	CbGeAlD
Ibuprofen—PPARG—endothelium—skin cancer	0.000996	0.0115	CbGeAlD
Ibuprofen—PTGS2—hindlimb—skin cancer	0.000983	0.0114	CbGeAlD
Ibuprofen—THBD—female reproductive system—skin cancer	0.000981	0.0113	CbGeAlD
Ibuprofen—BCL2—connective tissue—skin cancer	0.00098	0.0113	CbGeAlD
Ibuprofen—CFTR—epithelium—skin cancer	0.000942	0.0109	CbGeAlD
Ibuprofen—BCL2—epithelium—skin cancer	0.000931	0.0108	CbGeAlD
Ibuprofen—PPARG—blood vessel—skin cancer	0.000919	0.0106	CbGeAlD
Ibuprofen—FABP2—lymph node—skin cancer	0.000897	0.0104	CbGeAlD
Ibuprofen—BCL2—skin of body—skin cancer	0.000885	0.0102	CbGeAlD
Ibuprofen—PTGS2—appendage—skin cancer	0.000843	0.00974	CbGeAlD
Ibuprofen—THBD—head—skin cancer	0.00082	0.00947	CbGeAlD
Ibuprofen—PLAT—mammalian vulva—skin cancer	0.000807	0.00933	CbGeAlD
Ibuprofen—ABCC1—hair follicle—skin cancer	0.000758	0.00876	CbGeAlD
Ibuprofen—BCL2—lymphoid tissue—skin cancer	0.000717	0.00828	CbGeAlD
Ibuprofen—PTGS2—skin epidermis—skin cancer	0.000702	0.00811	CbGeAlD
Ibuprofen—CFTR—female reproductive system—skin cancer	0.0007	0.00809	CbGeAlD
Ibuprofen—BCL2—female reproductive system—skin cancer	0.000691	0.00799	CbGeAlD
Ibuprofen—PPARG—nipple—skin cancer	0.000664	0.00767	CbGeAlD
Ibuprofen—PPARG—neck—skin cancer	0.000657	0.00759	CbGeAlD
Ibuprofen—Carprofen—PTGS2—skin cancer	0.000622	0.335	CrCbGaD
Ibuprofen—CFTR—head—skin cancer	0.000585	0.00676	CbGeAlD
Ibuprofen—BCL2—head—skin cancer	0.000578	0.00667	CbGeAlD
Ibuprofen—THBD—lymph node—skin cancer	0.000574	0.00663	CbGeAlD
Ibuprofen—UGT2B7—female reproductive system—skin cancer	0.000544	0.00629	CbGeAlD
Ibuprofen—PTGS1—endothelium—skin cancer	0.000533	0.00615	CbGeAlD
Ibuprofen—SLC22A11—female reproductive system—skin cancer	0.000531	0.00613	CbGeAlD
Ibuprofen—ABCC1—nipple—skin cancer	0.000514	0.00594	CbGeAlD
Ibuprofen—PTGS2—endothelium—skin cancer	0.000509	0.00588	CbGeAlD
Ibuprofen—PTGS1—blood vessel—skin cancer	0.000491	0.00567	CbGeAlD
Ibuprofen—PPARG—connective tissue—skin cancer	0.000471	0.00544	CbGeAlD
Ibuprofen—PTGS2—blood vessel—skin cancer	0.000469	0.00542	CbGeAlD
Ibuprofen—PPARG—epithelium—skin cancer	0.000447	0.00517	CbGeAlD
Ibuprofen—PPARG—skin of body—skin cancer	0.000425	0.00491	CbGeAlD
Ibuprofen—BCL2—lymph node—skin cancer	0.000404	0.00467	CbGeAlD
Ibuprofen—PLAT—lymph node—skin cancer	0.000404	0.00467	CbGeAlD
Ibuprofen—PPARG—mammalian vulva—skin cancer	0.000388	0.00448	CbGeAlD
Ibuprofen—Suprofen—PTGS2—skin cancer	0.000384	0.207	CrCbGaD
Ibuprofen—CXCL8—lymph node—skin cancer	0.000375	0.00433	CbGeAlD
Ibuprofen—PTGS1—nipple—skin cancer	0.000355	0.0041	CbGeAlD
Ibuprofen—PPARG—lymphoid tissue—skin cancer	0.000344	0.00398	CbGeAlD
Ibuprofen—SLCO2B1—female reproductive system—skin cancer	0.000341	0.00394	CbGeAlD
Ibuprofen—PPARG—female reproductive system—skin cancer	0.000332	0.00384	CbGeAlD
Ibuprofen—Fenoprofen—PTGS2—skin cancer	0.000331	0.179	CrCbGaD
Ibuprofen—Naproxen—PTGS2—skin cancer	0.000302	0.163	CrCbGaD
Ibuprofen—ABCC4—female reproductive system—skin cancer	0.000302	0.00349	CbGeAlD
Ibuprofen—ABCC1—mammalian vulva—skin cancer	0.0003	0.00347	CbGeAlD
Ibuprofen—ABCB1—blood vessel—skin cancer	0.00029	0.00335	CbGeAlD
Ibuprofen—SLCO2B1—head—skin cancer	0.000285	0.00329	CbGeAlD
Ibuprofen—PPARG—head—skin cancer	0.000278	0.00321	CbGeAlD
Ibuprofen—SLCO1A2—head—skin cancer	0.000262	0.00303	CbGeAlD
Ibuprofen—ABCC4—head—skin cancer	0.000252	0.00291	CbGeAlD
Ibuprofen—PTGS1—connective tissue—skin cancer	0.000252	0.00291	CbGeAlD
Ibuprofen—SLC22A8—head—skin cancer	0.00025	0.00289	CbGeAlD
Ibuprofen—PTGS2—connective tissue—skin cancer	0.000241	0.00278	CbGeAlD
Ibuprofen—PTGS1—epithelium—skin cancer	0.000239	0.00276	CbGeAlD
Ibuprofen—PTGS2—epithelium—skin cancer	0.000229	0.00264	CbGeAlD
Ibuprofen—PTGS1—skin of body—skin cancer	0.000227	0.00263	CbGeAlD
Ibuprofen—CYP2C8—female reproductive system—skin cancer	0.000219	0.00253	CbGeAlD
Ibuprofen—PTGS2—skin of body—skin cancer	0.000217	0.00251	CbGeAlD
Ibuprofen—Flurbiprofen—PTGS2—skin cancer	0.000216	0.117	CrCbGaD
Ibuprofen—PTGS1—mammalian vulva—skin cancer	0.000207	0.0024	CbGeAlD
Ibuprofen—SLCO2B1—lymph node—skin cancer	0.000199	0.0023	CbGeAlD
Ibuprofen—CYP2C9—female reproductive system—skin cancer	0.000195	0.00225	CbGeAlD
Ibuprofen—PPARG—lymph node—skin cancer	0.000194	0.00225	CbGeAlD
Ibuprofen—ALB—lymph node—skin cancer	0.000182	0.00211	CbGeAlD
Ibuprofen—PTGS1—female reproductive system—skin cancer	0.000178	0.00205	CbGeAlD
Ibuprofen—ABCC4—lymph node—skin cancer	0.000176	0.00204	CbGeAlD
Ibuprofen—PTGS2—lymphoid tissue—skin cancer	0.000176	0.00203	CbGeAlD
Ibuprofen—PTGS2—female reproductive system—skin cancer	0.00017	0.00196	CbGeAlD
Ibuprofen—Haemoglobin—Fluorouracil—skin cancer	0.000161	0.00114	CcSEcCtD
Ibuprofen—Leukopenia—Bleomycin—skin cancer	0.00016	0.00114	CcSEcCtD
Ibuprofen—Rhinitis—Fluorouracil—skin cancer	0.00016	0.00114	CcSEcCtD
Ibuprofen—Haemorrhage—Fluorouracil—skin cancer	0.00016	0.00114	CcSEcCtD
Ibuprofen—Dizziness—Vemurafenib—skin cancer	0.000159	0.00114	CcSEcCtD
Ibuprofen—Pharyngitis—Fluorouracil—skin cancer	0.000159	0.00113	CcSEcCtD
Ibuprofen—Immune system disorder—Temozolomide—skin cancer	0.000157	0.00112	CcSEcCtD
Ibuprofen—Mediastinal disorder—Temozolomide—skin cancer	0.000156	0.00111	CcSEcCtD
Ibuprofen—Cough—Bleomycin—skin cancer	0.000156	0.00111	CcSEcCtD
Ibuprofen—Chills—Temozolomide—skin cancer	0.000156	0.00111	CcSEcCtD
Ibuprofen—Ill-defined disorder—Dactinomycin—skin cancer	0.000155	0.0011	CcSEcCtD
Ibuprofen—Anaemia—Dactinomycin—skin cancer	0.000154	0.0011	CcSEcCtD
Ibuprofen—Liver function test abnormal—Docetaxel—skin cancer	0.000154	0.0011	CcSEcCtD
Ibuprofen—Vomiting—Vemurafenib—skin cancer	0.000153	0.00109	CcSEcCtD
Ibuprofen—Alopecia—Temozolomide—skin cancer	0.000153	0.00109	CcSEcCtD
Ibuprofen—Myalgia—Bleomycin—skin cancer	0.000152	0.00109	CcSEcCtD
Ibuprofen—Abdominal pain upper—Docetaxel—skin cancer	0.000152	0.00108	CcSEcCtD
Ibuprofen—Rash—Vemurafenib—skin cancer	0.000152	0.00108	CcSEcCtD
Ibuprofen—Mental disorder—Temozolomide—skin cancer	0.000152	0.00108	CcSEcCtD
Ibuprofen—Dermatitis—Vemurafenib—skin cancer	0.000152	0.00108	CcSEcCtD
Ibuprofen—Hypersensitivity—Imiquimod—skin cancer	0.000152	0.00108	CcSEcCtD
Ibuprofen—Headache—Vemurafenib—skin cancer	0.000151	0.00108	CcSEcCtD
Ibuprofen—Malnutrition—Temozolomide—skin cancer	0.000151	0.00108	CcSEcCtD
Ibuprofen—Erythema—Temozolomide—skin cancer	0.000151	0.00108	CcSEcCtD
Ibuprofen—Discomfort—Bleomycin—skin cancer	0.000151	0.00107	CcSEcCtD
Ibuprofen—Malaise—Dactinomycin—skin cancer	0.000151	0.00107	CcSEcCtD
Ibuprofen—ABCC1—lymph node—skin cancer	0.00015	0.00174	CbGeAlD
Ibuprofen—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00015	0.00107	CcSEcCtD
Ibuprofen—Cramp muscle—Docetaxel—skin cancer	0.00015	0.00107	CcSEcCtD
Ibuprofen—Leukopenia—Dactinomycin—skin cancer	0.000149	0.00106	CcSEcCtD
Ibuprofen—PTGS1—head—skin cancer	0.000148	0.00171	CbGeAlD
Ibuprofen—Dysgeusia—Temozolomide—skin cancer	0.000148	0.00105	CcSEcCtD
Ibuprofen—Asthenia—Imiquimod—skin cancer	0.000148	0.00105	CcSEcCtD
Ibuprofen—Confusional state—Bleomycin—skin cancer	0.000147	0.00105	CcSEcCtD
Ibuprofen—Anaphylactic shock—Bleomycin—skin cancer	0.000146	0.00104	CcSEcCtD
Ibuprofen—Oedema—Bleomycin—skin cancer	0.000146	0.00104	CcSEcCtD
Ibuprofen—Pruritus—Imiquimod—skin cancer	0.000145	0.00104	CcSEcCtD
Ibuprofen—Infection—Bleomycin—skin cancer	0.000145	0.00103	CcSEcCtD
Ibuprofen—Dysphagia—Docetaxel—skin cancer	0.000144	0.00103	CcSEcCtD
Ibuprofen—Nausea—Vemurafenib—skin cancer	0.000143	0.00102	CcSEcCtD
Ibuprofen—Thrombocytopenia—Bleomycin—skin cancer	0.000143	0.00102	CcSEcCtD
Ibuprofen—Arrhythmia—Fluorouracil—skin cancer	0.000143	0.00102	CcSEcCtD
Ibuprofen—Vision blurred—Temozolomide—skin cancer	0.000142	0.00101	CcSEcCtD
Ibuprofen—Myalgia—Dactinomycin—skin cancer	0.000142	0.00101	CcSEcCtD
Ibuprofen—PTGS2—head—skin cancer	0.000142	0.00164	CbGeAlD
Ibuprofen—Bronchospasm—Docetaxel—skin cancer	0.000142	0.00101	CcSEcCtD
Ibuprofen—Tremor—Temozolomide—skin cancer	0.000141	0.00101	CcSEcCtD
Ibuprofen—ABCB1—epithelium—skin cancer	0.000141	0.00163	CbGeAlD
Ibuprofen—Alopecia—Fluorouracil—skin cancer	0.000141	0.00101	CcSEcCtD
Ibuprofen—Diarrhoea—Imiquimod—skin cancer	0.000141	0.001	CcSEcCtD
Ibuprofen—Discomfort—Dactinomycin—skin cancer	0.00014	0.001	CcSEcCtD
Ibuprofen—Ill-defined disorder—Temozolomide—skin cancer	0.00014	0.000998	CcSEcCtD
Ibuprofen—Anaemia—Temozolomide—skin cancer	0.00014	0.000994	CcSEcCtD
Ibuprofen—Anorexia—Bleomycin—skin cancer	0.000139	0.000992	CcSEcCtD
Ibuprofen—Erythema—Fluorouracil—skin cancer	0.000139	0.000991	CcSEcCtD
Ibuprofen—Agitation—Temozolomide—skin cancer	0.000139	0.000988	CcSEcCtD
Ibuprofen—Angioedema—Temozolomide—skin cancer	0.000138	0.000982	CcSEcCtD
Ibuprofen—Pancytopenia—Docetaxel—skin cancer	0.000137	0.000974	CcSEcCtD
Ibuprofen—Hypotension—Bleomycin—skin cancer	0.000137	0.000972	CcSEcCtD
Ibuprofen—Oedema—Dactinomycin—skin cancer	0.000136	0.00097	CcSEcCtD
Ibuprofen—Malaise—Temozolomide—skin cancer	0.000136	0.00097	CcSEcCtD
Ibuprofen—Dizziness—Imiquimod—skin cancer	0.000136	0.000968	CcSEcCtD
Ibuprofen—Vertigo—Temozolomide—skin cancer	0.000136	0.000966	CcSEcCtD
Ibuprofen—Infection—Dactinomycin—skin cancer	0.000135	0.000964	CcSEcCtD
Ibuprofen—Leukopenia—Temozolomide—skin cancer	0.000135	0.000962	CcSEcCtD
Ibuprofen—Neutropenia—Docetaxel—skin cancer	0.000135	0.00096	CcSEcCtD
Ibuprofen—Palpitations—Temozolomide—skin cancer	0.000133	0.00095	CcSEcCtD
Ibuprofen—Thrombocytopenia—Dactinomycin—skin cancer	0.000133	0.00095	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000133	0.000948	CcSEcCtD
Ibuprofen—Cough—Temozolomide—skin cancer	0.000132	0.000938	CcSEcCtD
Ibuprofen—Paraesthesia—Bleomycin—skin cancer	0.000131	0.000934	CcSEcCtD
Ibuprofen—Vision blurred—Fluorouracil—skin cancer	0.000131	0.000934	CcSEcCtD
Ibuprofen—Convulsion—Temozolomide—skin cancer	0.000131	0.000932	CcSEcCtD
Ibuprofen—Vomiting—Imiquimod—skin cancer	0.000131	0.000931	CcSEcCtD
Ibuprofen—Weight decreased—Docetaxel—skin cancer	0.00013	0.000928	CcSEcCtD
Ibuprofen—Hypertension—Temozolomide—skin cancer	0.00013	0.000928	CcSEcCtD
Ibuprofen—Dyspnoea—Bleomycin—skin cancer	0.00013	0.000927	CcSEcCtD
Ibuprofen—Anorexia—Dactinomycin—skin cancer	0.00013	0.000925	CcSEcCtD
Ibuprofen—Rash—Imiquimod—skin cancer	0.00013	0.000923	CcSEcCtD
Ibuprofen—Dermatitis—Imiquimod—skin cancer	0.00013	0.000922	CcSEcCtD
Ibuprofen—Pneumonia—Docetaxel—skin cancer	0.000129	0.00092	CcSEcCtD
Ibuprofen—Headache—Imiquimod—skin cancer	0.000129	0.000917	CcSEcCtD
Ibuprofen—Anaemia—Fluorouracil—skin cancer	0.000129	0.000916	CcSEcCtD
Ibuprofen—Myalgia—Temozolomide—skin cancer	0.000129	0.000915	CcSEcCtD
Ibuprofen—Arthralgia—Temozolomide—skin cancer	0.000129	0.000915	CcSEcCtD
Ibuprofen—Anxiety—Temozolomide—skin cancer	0.000128	0.000912	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000128	0.000909	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000127	0.000907	CcSEcCtD
Ibuprofen—Discomfort—Temozolomide—skin cancer	0.000127	0.000904	CcSEcCtD
Ibuprofen—Decreased appetite—Bleomycin—skin cancer	0.000127	0.000904	CcSEcCtD
Ibuprofen—Acute coronary syndrome—Docetaxel—skin cancer	0.000127	0.000902	CcSEcCtD
Ibuprofen—Renal failure—Docetaxel—skin cancer	0.000126	0.000899	CcSEcCtD
Ibuprofen—Myocardial infarction—Docetaxel—skin cancer	0.000126	0.000897	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Docetaxel—skin cancer	0.000126	0.000897	CcSEcCtD
Ibuprofen—Dry mouth—Temozolomide—skin cancer	0.000126	0.000895	CcSEcCtD
Ibuprofen—Stomatitis—Docetaxel—skin cancer	0.000125	0.000892	CcSEcCtD
Ibuprofen—Jaundice—Docetaxel—skin cancer	0.000125	0.000892	CcSEcCtD
Ibuprofen—Conjunctivitis—Docetaxel—skin cancer	0.000125	0.000889	CcSEcCtD
Ibuprofen—Leukopenia—Fluorouracil—skin cancer	0.000125	0.000887	CcSEcCtD
Ibuprofen—Confusional state—Temozolomide—skin cancer	0.000124	0.000885	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000124	0.000884	CcSEcCtD
Ibuprofen—Anaphylactic shock—Temozolomide—skin cancer	0.000123	0.000877	CcSEcCtD
Ibuprofen—Oedema—Temozolomide—skin cancer	0.000123	0.000877	CcSEcCtD
Ibuprofen—ABCB1—mammalian vulva—skin cancer	0.000123	0.00142	CbGeAlD
Ibuprofen—Infection—Temozolomide—skin cancer	0.000122	0.000872	CcSEcCtD
Ibuprofen—Nausea—Imiquimod—skin cancer	0.000122	0.00087	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Docetaxel—skin cancer	0.000122	0.000865	CcSEcCtD
Ibuprofen—Epistaxis—Docetaxel—skin cancer	0.000121	0.000863	CcSEcCtD
Ibuprofen—Nervous system disorder—Temozolomide—skin cancer	0.000121	0.000861	CcSEcCtD
Ibuprofen—Thrombocytopenia—Temozolomide—skin cancer	0.000121	0.000859	CcSEcCtD
Ibuprofen—Convulsion—Fluorouracil—skin cancer	0.000121	0.000858	CcSEcCtD
Ibuprofen—Feeling abnormal—Bleomycin—skin cancer	0.00012	0.000857	CcSEcCtD
Ibuprofen—Agranulocytosis—Docetaxel—skin cancer	0.00012	0.000854	CcSEcCtD
Ibuprofen—Skin disorder—Temozolomide—skin cancer	0.00012	0.000852	CcSEcCtD
Ibuprofen—Hyperhidrosis—Temozolomide—skin cancer	0.000119	0.000848	CcSEcCtD
Ibuprofen—Myalgia—Fluorouracil—skin cancer	0.000118	0.000843	CcSEcCtD
Ibuprofen—Decreased appetite—Dactinomycin—skin cancer	0.000118	0.000843	CcSEcCtD
Ibuprofen—Fatigue—Dactinomycin—skin cancer	0.000117	0.000836	CcSEcCtD
Ibuprofen—Anorexia—Temozolomide—skin cancer	0.000117	0.000836	CcSEcCtD
Ibuprofen—Discomfort—Fluorouracil—skin cancer	0.000117	0.000833	CcSEcCtD
Ibuprofen—Urticaria—Bleomycin—skin cancer	0.000116	0.000826	CcSEcCtD
Ibuprofen—Haemoglobin—Docetaxel—skin cancer	0.000116	0.000826	CcSEcCtD
Ibuprofen—Rhinitis—Docetaxel—skin cancer	0.000116	0.000823	CcSEcCtD
Ibuprofen—Hepatitis—Docetaxel—skin cancer	0.000115	0.000821	CcSEcCtD
Ibuprofen—Haemorrhage—Docetaxel—skin cancer	0.000115	0.000821	CcSEcCtD
Ibuprofen—Confusional state—Fluorouracil—skin cancer	0.000114	0.000815	CcSEcCtD
Ibuprofen—Pharyngitis—Docetaxel—skin cancer	0.000114	0.000815	CcSEcCtD
Ibuprofen—Urinary tract disorder—Docetaxel—skin cancer	0.000114	0.000811	CcSEcCtD
Ibuprofen—Oedema peripheral—Docetaxel—skin cancer	0.000114	0.000809	CcSEcCtD
Ibuprofen—Oedema—Fluorouracil—skin cancer	0.000114	0.000808	CcSEcCtD
Ibuprofen—Anaphylactic shock—Fluorouracil—skin cancer	0.000114	0.000808	CcSEcCtD
Ibuprofen—Urethral disorder—Docetaxel—skin cancer	0.000113	0.000805	CcSEcCtD
Ibuprofen—Infection—Fluorouracil—skin cancer	0.000113	0.000803	CcSEcCtD
Ibuprofen—Feeling abnormal—Dactinomycin—skin cancer	0.000112	0.000799	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000112	0.000799	CcSEcCtD
Ibuprofen—Insomnia—Temozolomide—skin cancer	0.000111	0.000794	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Dactinomycin—skin cancer	0.000111	0.000793	CcSEcCtD
Ibuprofen—Nervous system disorder—Fluorouracil—skin cancer	0.000111	0.000793	CcSEcCtD
Ibuprofen—Thrombocytopenia—Fluorouracil—skin cancer	0.000111	0.000792	CcSEcCtD
Ibuprofen—Visual impairment—Docetaxel—skin cancer	0.000111	0.000792	CcSEcCtD
Ibuprofen—Tachycardia—Fluorouracil—skin cancer	0.000111	0.000789	CcSEcCtD
Ibuprofen—Paraesthesia—Temozolomide—skin cancer	0.000111	0.000788	CcSEcCtD
Ibuprofen—Dyspnoea—Temozolomide—skin cancer	0.00011	0.000782	CcSEcCtD
Ibuprofen—Somnolence—Temozolomide—skin cancer	0.00011	0.00078	CcSEcCtD
Ibuprofen—Erythema multiforme—Docetaxel—skin cancer	0.000109	0.000777	CcSEcCtD
Ibuprofen—ABCB1—lymphoid tissue—skin cancer	0.000109	0.00126	CbGeAlD
Ibuprofen—Dyspepsia—Temozolomide—skin cancer	0.000108	0.000772	CcSEcCtD
Ibuprofen—Anorexia—Fluorouracil—skin cancer	0.000108	0.000771	CcSEcCtD
Ibuprofen—Abdominal pain—Dactinomycin—skin cancer	0.000108	0.000767	CcSEcCtD
Ibuprofen—Hypersensitivity—Bleomycin—skin cancer	0.000108	0.000766	CcSEcCtD
Ibuprofen—Decreased appetite—Temozolomide—skin cancer	0.000107	0.000763	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Temozolomide—skin cancer	0.000106	0.000758	CcSEcCtD
Ibuprofen—Fatigue—Temozolomide—skin cancer	0.000106	0.000757	CcSEcCtD
Ibuprofen—Hypotension—Fluorouracil—skin cancer	0.000106	0.000755	CcSEcCtD
Ibuprofen—Constipation—Temozolomide—skin cancer	0.000105	0.00075	CcSEcCtD
Ibuprofen—ABCB1—female reproductive system—skin cancer	0.000105	0.00121	CbGeAlD
Ibuprofen—Asthenia—Bleomycin—skin cancer	0.000105	0.000746	CcSEcCtD
Ibuprofen—Immune system disorder—Docetaxel—skin cancer	0.000104	0.000742	CcSEcCtD
Ibuprofen—Mediastinal disorder—Docetaxel—skin cancer	0.000104	0.00074	CcSEcCtD
Ibuprofen—PTGS1—lymph node—skin cancer	0.000104	0.0012	CbGeAlD
Ibuprofen—Chills—Docetaxel—skin cancer	0.000104	0.000737	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000103	0.000737	CcSEcCtD
Ibuprofen—Pruritus—Bleomycin—skin cancer	0.000103	0.000736	CcSEcCtD
Ibuprofen—Arrhythmia—Docetaxel—skin cancer	0.000103	0.000734	CcSEcCtD
Ibuprofen—Insomnia—Fluorouracil—skin cancer	0.000103	0.000731	CcSEcCtD
Ibuprofen—Paraesthesia—Fluorouracil—skin cancer	0.000102	0.000726	CcSEcCtD
Ibuprofen—Alopecia—Docetaxel—skin cancer	0.000102	0.000726	CcSEcCtD
Ibuprofen—Feeling abnormal—Temozolomide—skin cancer	0.000102	0.000723	CcSEcCtD
Ibuprofen—Dyspnoea—Fluorouracil—skin cancer	0.000101	0.000721	CcSEcCtD
Ibuprofen—Mental disorder—Docetaxel—skin cancer	0.000101	0.00072	CcSEcCtD
Ibuprofen—Somnolence—Fluorouracil—skin cancer	0.000101	0.000719	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Temozolomide—skin cancer	0.000101	0.000718	CcSEcCtD
Ibuprofen—Erythema—Docetaxel—skin cancer	0.0001	0.000715	CcSEcCtD
Ibuprofen—Malnutrition—Docetaxel—skin cancer	0.0001	0.000715	CcSEcCtD
Ibuprofen—Hypersensitivity—Dactinomycin—skin cancer	0.0001	0.000715	CcSEcCtD
Ibuprofen—Dyspepsia—Fluorouracil—skin cancer	0.0001	0.000712	CcSEcCtD
Ibuprofen—PTGS2—lymph node—skin cancer	9.93e-05	0.00115	CbGeAlD
Ibuprofen—Decreased appetite—Fluorouracil—skin cancer	9.87e-05	0.000703	CcSEcCtD
Ibuprofen—Dysgeusia—Docetaxel—skin cancer	9.83e-05	0.0007	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Fluorouracil—skin cancer	9.8e-05	0.000698	CcSEcCtD
Ibuprofen—Urticaria—Temozolomide—skin cancer	9.79e-05	0.000697	CcSEcCtD
Ibuprofen—Asthenia—Dactinomycin—skin cancer	9.78e-05	0.000696	CcSEcCtD
Ibuprofen—Abdominal pain—Temozolomide—skin cancer	9.74e-05	0.000694	CcSEcCtD
Ibuprofen—Muscle spasms—Docetaxel—skin cancer	9.65e-05	0.000687	CcSEcCtD
Ibuprofen—Feeling abnormal—Fluorouracil—skin cancer	9.36e-05	0.000666	CcSEcCtD
Ibuprofen—Diarrhoea—Dactinomycin—skin cancer	9.32e-05	0.000664	CcSEcCtD
Ibuprofen—Vomiting—Bleomycin—skin cancer	9.29e-05	0.000661	CcSEcCtD
Ibuprofen—Anaemia—Docetaxel—skin cancer	9.28e-05	0.000661	CcSEcCtD
Ibuprofen—Rash—Bleomycin—skin cancer	9.21e-05	0.000656	CcSEcCtD
Ibuprofen—Dermatitis—Bleomycin—skin cancer	9.2e-05	0.000655	CcSEcCtD
Ibuprofen—Hypersensitivity—Temozolomide—skin cancer	9.08e-05	0.000646	CcSEcCtD
Ibuprofen—Urticaria—Fluorouracil—skin cancer	9.02e-05	0.000642	CcSEcCtD
Ibuprofen—Syncope—Docetaxel—skin cancer	9.01e-05	0.000641	CcSEcCtD
Ibuprofen—Leukopenia—Docetaxel—skin cancer	8.99e-05	0.00064	CcSEcCtD
Ibuprofen—Palpitations—Docetaxel—skin cancer	8.87e-05	0.000632	CcSEcCtD
Ibuprofen—Asthenia—Temozolomide—skin cancer	8.84e-05	0.00063	CcSEcCtD
Ibuprofen—Loss of consciousness—Docetaxel—skin cancer	8.83e-05	0.000628	CcSEcCtD
Ibuprofen—ABCB1—head—skin cancer	8.77e-05	0.00101	CbGeAlD
Ibuprofen—Cough—Docetaxel—skin cancer	8.76e-05	0.000624	CcSEcCtD
Ibuprofen—Pruritus—Temozolomide—skin cancer	8.72e-05	0.000621	CcSEcCtD
Ibuprofen—Convulsion—Docetaxel—skin cancer	8.7e-05	0.000619	CcSEcCtD
Ibuprofen—Nausea—Bleomycin—skin cancer	8.68e-05	0.000618	CcSEcCtD
Ibuprofen—Hypertension—Docetaxel—skin cancer	8.67e-05	0.000617	CcSEcCtD
Ibuprofen—Vomiting—Dactinomycin—skin cancer	8.66e-05	0.000617	CcSEcCtD
Ibuprofen—Rash—Dactinomycin—skin cancer	8.59e-05	0.000612	CcSEcCtD
Ibuprofen—Arthralgia—Docetaxel—skin cancer	8.55e-05	0.000609	CcSEcCtD
Ibuprofen—Myalgia—Docetaxel—skin cancer	8.55e-05	0.000609	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	8.49e-05	0.000605	CcSEcCtD
Ibuprofen—Diarrhoea—Temozolomide—skin cancer	8.43e-05	0.0006	CcSEcCtD
Ibuprofen—Hypersensitivity—Fluorouracil—skin cancer	8.37e-05	0.000596	CcSEcCtD
Ibuprofen—Dry mouth—Docetaxel—skin cancer	8.36e-05	0.000595	CcSEcCtD
Ibuprofen—Confusional state—Docetaxel—skin cancer	8.26e-05	0.000588	CcSEcCtD
Ibuprofen—Oedema—Docetaxel—skin cancer	8.2e-05	0.000584	CcSEcCtD
Ibuprofen—Anaphylactic shock—Docetaxel—skin cancer	8.2e-05	0.000584	CcSEcCtD
Ibuprofen—Dizziness—Temozolomide—skin cancer	8.15e-05	0.00058	CcSEcCtD
Ibuprofen—Infection—Docetaxel—skin cancer	8.14e-05	0.00058	CcSEcCtD
Ibuprofen—Nausea—Dactinomycin—skin cancer	8.09e-05	0.000576	CcSEcCtD
Ibuprofen—Shock—Docetaxel—skin cancer	8.06e-05	0.000574	CcSEcCtD
Ibuprofen—Nervous system disorder—Docetaxel—skin cancer	8.04e-05	0.000572	CcSEcCtD
Ibuprofen—Pruritus—Fluorouracil—skin cancer	8.03e-05	0.000572	CcSEcCtD
Ibuprofen—Thrombocytopenia—Docetaxel—skin cancer	8.02e-05	0.000571	CcSEcCtD
Ibuprofen—Tachycardia—Docetaxel—skin cancer	8e-05	0.00057	CcSEcCtD
Ibuprofen—Skin disorder—Docetaxel—skin cancer	7.96e-05	0.000567	CcSEcCtD
Ibuprofen—Vomiting—Temozolomide—skin cancer	7.84e-05	0.000558	CcSEcCtD
Ibuprofen—Anorexia—Docetaxel—skin cancer	7.81e-05	0.000556	CcSEcCtD
Ibuprofen—Rash—Temozolomide—skin cancer	7.77e-05	0.000553	CcSEcCtD
Ibuprofen—Diarrhoea—Fluorouracil—skin cancer	7.77e-05	0.000553	CcSEcCtD
Ibuprofen—Dermatitis—Temozolomide—skin cancer	7.76e-05	0.000553	CcSEcCtD
Ibuprofen—Headache—Temozolomide—skin cancer	7.72e-05	0.00055	CcSEcCtD
Ibuprofen—Hypotension—Docetaxel—skin cancer	7.66e-05	0.000545	CcSEcCtD
Ibuprofen—Dizziness—Fluorouracil—skin cancer	7.51e-05	0.000535	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Docetaxel—skin cancer	7.47e-05	0.000532	CcSEcCtD
Ibuprofen—Insomnia—Docetaxel—skin cancer	7.41e-05	0.000528	CcSEcCtD
Ibuprofen—Paraesthesia—Docetaxel—skin cancer	7.36e-05	0.000524	CcSEcCtD
Ibuprofen—Nausea—Temozolomide—skin cancer	7.32e-05	0.000521	CcSEcCtD
Ibuprofen—Dyspnoea—Docetaxel—skin cancer	7.31e-05	0.00052	CcSEcCtD
Ibuprofen—Somnolence—Docetaxel—skin cancer	7.29e-05	0.000519	CcSEcCtD
Ibuprofen—Vomiting—Fluorouracil—skin cancer	7.22e-05	0.000514	CcSEcCtD
Ibuprofen—Dyspepsia—Docetaxel—skin cancer	7.21e-05	0.000514	CcSEcCtD
Ibuprofen—Rash—Fluorouracil—skin cancer	7.16e-05	0.00051	CcSEcCtD
Ibuprofen—Dermatitis—Fluorouracil—skin cancer	7.15e-05	0.000509	CcSEcCtD
Ibuprofen—Decreased appetite—Docetaxel—skin cancer	7.12e-05	0.000507	CcSEcCtD
Ibuprofen—Headache—Fluorouracil—skin cancer	7.11e-05	0.000506	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Docetaxel—skin cancer	7.08e-05	0.000504	CcSEcCtD
Ibuprofen—Fatigue—Docetaxel—skin cancer	7.07e-05	0.000503	CcSEcCtD
Ibuprofen—Constipation—Docetaxel—skin cancer	7.01e-05	0.000499	CcSEcCtD
Ibuprofen—Feeling abnormal—Docetaxel—skin cancer	6.75e-05	0.000481	CcSEcCtD
Ibuprofen—Nausea—Fluorouracil—skin cancer	6.74e-05	0.00048	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Docetaxel—skin cancer	6.7e-05	0.000477	CcSEcCtD
Ibuprofen—Abdominal pain—Docetaxel—skin cancer	6.48e-05	0.000461	CcSEcCtD
Ibuprofen—ABCB1—lymph node—skin cancer	6.14e-05	0.00071	CbGeAlD
Ibuprofen—Hypersensitivity—Docetaxel—skin cancer	6.04e-05	0.00043	CcSEcCtD
Ibuprofen—Asthenia—Docetaxel—skin cancer	5.88e-05	0.000419	CcSEcCtD
Ibuprofen—Pruritus—Docetaxel—skin cancer	5.8e-05	0.000413	CcSEcCtD
Ibuprofen—Diarrhoea—Docetaxel—skin cancer	5.61e-05	0.000399	CcSEcCtD
Ibuprofen—Dizziness—Docetaxel—skin cancer	5.42e-05	0.000386	CcSEcCtD
Ibuprofen—CXCL8—Cellular responses to stress—CDK4—skin cancer	5.4e-05	0.00134	CbGpPWpGaD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—IL6—skin cancer	5.36e-05	0.00133	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—GLI1—skin cancer	5.36e-05	0.00133	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	5.32e-05	0.00132	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—MC1R—skin cancer	5.31e-05	0.00132	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—CDK4—skin cancer	5.29e-05	0.00131	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—RASA1—skin cancer	5.26e-05	0.0013	CbGpPWpGaD
Ibuprofen—Vomiting—Docetaxel—skin cancer	5.21e-05	0.000371	CcSEcCtD
Ibuprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	5.21e-05	0.00129	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	5.2e-05	0.00129	CbGpPWpGaD
Ibuprofen—THBD—Hemostasis—HRAS—skin cancer	5.2e-05	0.00129	CbGpPWpGaD
Ibuprofen—Rash—Docetaxel—skin cancer	5.17e-05	0.000368	CcSEcCtD
Ibuprofen—Dermatitis—Docetaxel—skin cancer	5.16e-05	0.000368	CcSEcCtD
Ibuprofen—Headache—Docetaxel—skin cancer	5.13e-05	0.000366	CcSEcCtD
Ibuprofen—PLAT—Signaling by PDGF—HRAS—skin cancer	5.13e-05	0.00127	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	5.13e-05	0.00127	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—SUFU—skin cancer	5.08e-05	0.00126	CbGpPWpGaD
Ibuprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	5.07e-05	0.00126	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—FOXO4—skin cancer	5.03e-05	0.00125	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—TP53—skin cancer	5e-05	0.00124	CbGpPWpGaD
Ibuprofen—PLAT—Signaling by PDGF—IL6—skin cancer	4.91e-05	0.00122	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—ENO2—skin cancer	4.88e-05	0.00121	CbGpPWpGaD
Ibuprofen—Nausea—Docetaxel—skin cancer	4.87e-05	0.000347	CcSEcCtD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—TP53—skin cancer	4.85e-05	0.0012	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—skin cancer	4.8e-05	0.00119	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.79e-05	0.00119	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—HRAS—skin cancer	4.78e-05	0.00119	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PLIN2—skin cancer	4.78e-05	0.00118	CbGpPWpGaD
Ibuprofen—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	4.65e-05	0.00115	CbGpPWpGaD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—HRAS—skin cancer	4.64e-05	0.00115	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—skin cancer	4.59e-05	0.00114	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.58e-05	0.00114	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IL6—skin cancer	4.58e-05	0.00114	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	4.52e-05	0.00112	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—CDK4—skin cancer	4.51e-05	0.00112	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL6—skin cancer	4.5e-05	0.00112	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	4.46e-05	0.00111	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IL6—skin cancer	4.4e-05	0.00109	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—skin cancer	4.4e-05	0.00109	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—TP53—skin cancer	4.38e-05	0.00109	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTCH2—skin cancer	4.33e-05	0.00108	CbGpPWpGaD
Ibuprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	4.24e-05	0.00105	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	4.23e-05	0.00105	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—KRAS—skin cancer	4.21e-05	0.00104	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—CDKN2A—skin cancer	4.13e-05	0.00102	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PLIN2—skin cancer	4.06e-05	0.00101	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL6—skin cancer	4.01e-05	0.000994	CbGpPWpGaD
Ibuprofen—BCL2—Direct p53 effectors—TP53—skin cancer	3.97e-05	0.000985	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.9e-05	0.000968	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.9e-05	0.000966	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.88e-05	0.000962	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—SHH—skin cancer	3.87e-05	0.000961	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—CSPG4—skin cancer	3.85e-05	0.000955	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—RASA1—skin cancer	3.85e-05	0.000954	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—PTGER4—skin cancer	3.84e-05	0.000953	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PLIN2—skin cancer	3.84e-05	0.000952	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—SHH—skin cancer	3.78e-05	0.000938	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—TP53—skin cancer	3.74e-05	0.000927	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—PTCH1—skin cancer	3.67e-05	0.000911	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—SMO—skin cancer	3.67e-05	0.000911	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TP53—skin cancer	3.66e-05	0.000908	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—PTCH1—skin cancer	3.58e-05	0.000889	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—SMO—skin cancer	3.58e-05	0.000889	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—PTGER4—skin cancer	3.57e-05	0.000886	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PLIN2—skin cancer	3.54e-05	0.000877	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	3.51e-05	0.000872	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.5e-05	0.000867	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—PTGER4—skin cancer	3.49e-05	0.000865	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.49e-05	0.000865	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.48e-05	0.000864	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PLIN2—skin cancer	3.3e-05	0.000819	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PLIN2—skin cancer	3.3e-05	0.000819	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	3.3e-05	0.000817	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	3.29e-05	0.000816	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—GLI2—skin cancer	3.29e-05	0.000815	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—CSPG4—skin cancer	3.27e-05	0.000812	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL6—skin cancer	3.2e-05	0.000795	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PLIN2—skin cancer	3.18e-05	0.000789	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.17e-05	0.000788	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—FOXO4—skin cancer	3.16e-05	0.000783	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MC1R—skin cancer	3.13e-05	0.000777	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	3.1e-05	0.000769	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—NRAS—skin cancer	3.09e-05	0.000768	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—CSPG4—skin cancer	3.09e-05	0.000768	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—GLI1—skin cancer	3.09e-05	0.000766	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3.07e-05	0.000761	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.06e-05	0.00076	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CSPG4—skin cancer	3.06e-05	0.00076	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—TP53—skin cancer	3.04e-05	0.000754	CbGpPWpGaD
Ibuprofen—BCL2—Focal Adhesion—HRAS—skin cancer	2.98e-05	0.000738	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—FOXO4—skin cancer	2.93e-05	0.000727	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—SUFU—skin cancer	2.93e-05	0.000726	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—IL6—skin cancer	2.92e-05	0.000724	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—CSPG4—skin cancer	2.85e-05	0.000707	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—ERCC2—skin cancer	2.84e-05	0.000704	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	2.83e-05	0.000702	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	2.8e-05	0.000693	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—IL6—skin cancer	2.78e-05	0.00069	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.78e-05	0.000689	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PLIN2—skin cancer	2.69e-05	0.000667	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—KRAS—skin cancer	2.66e-05	0.000661	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—CSPG4—skin cancer	2.66e-05	0.00066	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—CSPG4—skin cancer	2.66e-05	0.00066	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—ENO2—skin cancer	2.62e-05	0.000649	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—CDK4—skin cancer	2.58e-05	0.000639	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—CSPG4—skin cancer	2.56e-05	0.000636	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TP53—skin cancer	2.47e-05	0.000612	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	2.41e-05	0.000597	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—TP53—skin cancer	2.37e-05	0.000587	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—TP53—skin cancer	2.3e-05	0.00057	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—HRAS—skin cancer	2.26e-05	0.000562	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IL6—skin cancer	2.26e-05	0.000561	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—TP53—skin cancer	2.25e-05	0.000558	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—SHH—skin cancer	2.23e-05	0.000554	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—ENO2—skin cancer	2.22e-05	0.000552	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—RASA1—skin cancer	2.22e-05	0.000551	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	2.22e-05	0.00055	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.17e-05	0.000539	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—CSPG4—skin cancer	2.17e-05	0.000538	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PLIN2—skin cancer	2.14e-05	0.00053	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTCH1—skin cancer	2.12e-05	0.000525	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—SMO—skin cancer	2.12e-05	0.000525	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TERT—skin cancer	2.11e-05	0.000523	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—ENO2—skin cancer	2.1e-05	0.000522	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—IL6—skin cancer	2.1e-05	0.000522	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—ENO2—skin cancer	2.08e-05	0.000516	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—SHH—skin cancer	2.08e-05	0.000516	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTGER4—skin cancer	2.06e-05	0.000511	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—IL6—skin cancer	2.06e-05	0.000511	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CSPG4—skin cancer	2.06e-05	0.00051	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—ENO2—skin cancer	1.94e-05	0.000481	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TP53—skin cancer	1.92e-05	0.000476	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—FOXO4—skin cancer	1.82e-05	0.000452	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ENO2—skin cancer	1.81e-05	0.000448	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—ENO2—skin cancer	1.81e-05	0.000448	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.8e-05	0.000445	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IL6—skin cancer	1.75e-05	0.000435	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ENO2—skin cancer	1.74e-05	0.000432	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PLIN2—skin cancer	1.74e-05	0.000431	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PLIN2—skin cancer	1.73e-05	0.000429	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CSPG4—skin cancer	1.72e-05	0.000427	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—PTGS2—skin cancer	1.7e-05	0.000422	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—FOXO4—skin cancer	1.7e-05	0.000421	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—NRAS—skin cancer	1.67e-05	0.000415	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—BRAF—skin cancer	1.67e-05	0.000414	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.65e-05	0.000408	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—ERCC2—skin cancer	1.57e-05	0.00039	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.55e-05	0.000385	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PLIN2—skin cancer	1.55e-05	0.000385	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—ERCC2—skin cancer	1.52e-05	0.000377	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.52e-05	0.000376	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PLIN2—skin cancer	1.51e-05	0.000375	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ENO2—skin cancer	1.47e-05	0.000366	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.47e-05	0.000364	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—KRAS—skin cancer	1.44e-05	0.000357	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—NRAS—skin cancer	1.43e-05	0.000356	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PLIN2—skin cancer	1.41e-05	0.000351	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.41e-05	0.000351	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CSPG4—skin cancer	1.4e-05	0.000347	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—NRAS—skin cancer	1.4e-05	0.000347	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ENO2—skin cancer	1.4e-05	0.000347	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SHH—skin cancer	1.4e-05	0.000347	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CSPG4—skin cancer	1.39e-05	0.000345	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.36e-05	0.000338	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.3e-05	0.000324	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—ERCC2—skin cancer	1.29e-05	0.000321	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CSPG4—skin cancer	1.25e-05	0.00031	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—KRAS—skin cancer	1.23e-05	0.000306	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—HRAS—skin cancer	1.22e-05	0.000304	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—ERCC2—skin cancer	1.22e-05	0.000303	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CSPG4—skin cancer	1.22e-05	0.000303	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TERT—skin cancer	1.22e-05	0.000302	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—ERCC2—skin cancer	1.21e-05	0.0003	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—KRAS—skin cancer	1.2e-05	0.000299	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—IL6—skin cancer	1.17e-05	0.00029	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ENO2—skin cancer	1.17e-05	0.00029	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.15e-05	0.000286	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CSPG4—skin cancer	1.14e-05	0.000283	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—FOXO4—skin cancer	1.14e-05	0.000283	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—TERT—skin cancer	1.13e-05	0.000281	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—ERCC2—skin cancer	1.13e-05	0.000279	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—TP53—skin cancer	1.07e-05	0.000265	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—ERCC2—skin cancer	1.05e-05	0.00026	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ERCC2—skin cancer	1.05e-05	0.00026	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—NRAS—skin cancer	1.05e-05	0.00026	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—HRAS—skin cancer	1.05e-05	0.00026	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.04e-05	0.000258	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—NRAS—skin cancer	1.02e-05	0.000254	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—HRAS—skin cancer	1.02e-05	0.000254	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ERCC2—skin cancer	1.01e-05	0.000251	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—IL6—skin cancer	1e-05	0.000249	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—NRAS—skin cancer	9.74e-06	0.000242	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—BRAF—skin cancer	9.63e-06	0.000239	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ENO2—skin cancer	9.52e-06	0.000236	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ENO2—skin cancer	9.46e-06	0.000235	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.24e-06	0.000229	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTGS2—skin cancer	9.11e-06	0.000226	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KRAS—skin cancer	9.03e-06	0.000224	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—BRAF—skin cancer	8.98e-06	0.000223	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—KRAS—skin cancer	8.82e-06	0.000219	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ERCC2—skin cancer	8.56e-06	0.000212	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ENO2—skin cancer	8.5e-06	0.000211	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KRAS—skin cancer	8.38e-06	0.000208	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ENO2—skin cancer	8.29e-06	0.000206	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ERCC2—skin cancer	8.11e-06	0.000201	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—skin cancer	8.03e-06	0.000199	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTGS2—skin cancer	7.75e-06	0.000192	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ENO2—skin cancer	7.75e-06	0.000192	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—HRAS—skin cancer	7.68e-06	0.00019	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TERT—skin cancer	7.61e-06	0.000189	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—HRAS—skin cancer	7.49e-06	0.000186	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.44e-06	0.000185	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.4e-06	0.000184	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL6—skin cancer	7.35e-06	0.000182	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTGS2—skin cancer	7.33e-06	0.000182	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTGS2—skin cancer	7.25e-06	0.00018	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL6—skin cancer	7.17e-06	0.000178	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HRAS—skin cancer	7.13e-06	0.000177	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL6—skin cancer	6.82e-06	0.000169	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ERCC2—skin cancer	6.8e-06	0.000169	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTGS2—skin cancer	6.75e-06	0.000167	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.64e-06	0.000165	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—NRAS—skin cancer	6.33e-06	0.000157	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTGS2—skin cancer	6.3e-06	0.000156	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTGS2—skin cancer	6.3e-06	0.000156	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTGS2—skin cancer	6.07e-06	0.000151	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.06e-06	0.00015	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—NRAS—skin cancer	6.05e-06	0.00015	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—BRAF—skin cancer	6.02e-06	0.000149	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NRAS—skin cancer	5.64e-06	0.00014	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ERCC2—skin cancer	5.53e-06	0.000137	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ERCC2—skin cancer	5.5e-06	0.000136	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—KRAS—skin cancer	5.44e-06	0.000135	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KRAS—skin cancer	5.21e-06	0.000129	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTGS2—skin cancer	5.13e-06	0.000127	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ERCC2—skin cancer	4.94e-06	0.000122	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KRAS—skin cancer	4.85e-06	0.00012	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—skin cancer	4.84e-06	0.00012	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ERCC2—skin cancer	4.82e-06	0.00012	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—skin cancer	4.63e-06	0.000115	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—HRAS—skin cancer	4.63e-06	0.000115	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ERCC2—skin cancer	4.5e-06	0.000112	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—HRAS—skin cancer	4.43e-06	0.00011	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL6—skin cancer	4.24e-06	0.000105	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HRAS—skin cancer	4.13e-06	0.000102	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—IL6—skin cancer	3.95e-06	9.8e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NRAS—skin cancer	3.79e-06	9.39e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS2—skin cancer	3.32e-06	8.22e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS2—skin cancer	3.3e-06	8.18e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KRAS—skin cancer	3.26e-06	8.08e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS2—skin cancer	2.96e-06	7.34e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS2—skin cancer	2.89e-06	7.17e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HRAS—skin cancer	2.77e-06	6.87e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS2—skin cancer	2.7e-06	6.69e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—IL6—skin cancer	2.65e-06	6.58e-05	CbGpPWpGaD
